Abstract
A low level of reproducibility is the shortcoming of clinical studies where human tissues are used, especially in oncology (EGAAP, Evaluation of Genomic Applications and Prevention Working Group (2013) Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy? Genet Med: Off J Am Coll Med Genet 15:517–527, Simon RM, Paik S, Hayes DF (2009) Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 101:1446–1452). This could be due to the high variability of the pre-analytical conditions of tissue managing and preservation, but also to other two causes. One is the low level of standardization of the methods that is pertinent to the analytical phase. Heterogeneity of tissues is the other problem and it can be considered to be actually related to pre-analytical procedures. Indeed, it is a pre-condition that has to be taken into consideration before the specific analysis. Not all the consequences of heterogeneity can be more or less easily avoided by carefully choosing the tissues to be analyzed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
EGAAP, Evaluation of Genomic Applications and Prevention Working Group (2013) Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy? Genet Med: Off J Am Coll Med Genet 15:517–527
Simon RM, Paik S, Hayes DF (2009) Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 101:1446–1452
Elloumi F, Hu Z, Li Y et al (2011) Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples. BMC Med Genomics 4:54
Hlubek F, Brabletz T, Budczies J, Pfeiffer S, Jung A, Kirchner T (2007) Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer. Int J Cancer 1:1941–1948
Gerlinger M et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892
Aparicio S, Caldas C (2013) The implications of clonal genome evolution for cancer medicine. N Engl J Med 368:842–851
Misale S et al (2012) Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486:532–536
Rashid A, Issa JP (2004) CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 127:1578–1588
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22:231–237
Feron O (2009) Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 92:329–333
Kennedy KM, Dewhirst MW (2010) Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol 6:127
Schito L et al (2012) Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci USA 109:E2707–E2716
Marotta LLC et al (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell—like breast cancer cells in human tumors. J Clin Investig 121:2723–2735
Korkaya H, Liu S, Wicha MS (2011) Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Investig 121:3804–3809
Okuda H et al (2013) miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 73:1434–1444
Watabe K (2013) MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients. American Association for Cancer Research, February 5. http://www.aacr.org
Li GW, Xie XS (2011) Central dogma at the single-molecule level in living cells. Nature 475:308–315
Spencer SL et al (2009) Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459:428–432
Barga A et al (2011) Predicting mutation outcome from early stochastic variation in genetic interaction partners. Nature 480:250–253
Alamgeer M, Ganju V, Watkins DN (2013) Novel therapeutic targets in non-small cell lung cancer. Curr Opin Pharmacol 13:394–401
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Stanta, G. (2015). Tissue Heterogeneity as a Pre-analytical Source of Variability. In: Dietel, M., Wittekind, C., Bussolati, G., von Winterfeld, M. (eds) Pre-Analytics of Pathological Specimens in Oncology. Recent Results in Cancer Research, vol 199. Springer, Cham. https://doi.org/10.1007/978-3-319-13957-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-13957-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13956-2
Online ISBN: 978-3-319-13957-9
eBook Packages: MedicineMedicine (R0)